Thermo Fisher Scientific ... (TMO)
Thermo Fisher Scientific Statistics
Share Statistics
Thermo Fisher Scientific has 377.49M shares outstanding. The number of shares has increased by -1.17% in one year.
| Shares Outstanding | 377.49M |
| Shares Change (YoY) | -1.17% |
| Shares Change (QoQ) | -1.37% |
| Owned by Institutions (%) | 88.25% |
| Shares Floating | 376.84M |
| Failed to Deliver (FTD) Shares | 88 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 3.94M, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 3.94M |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 2.45 |
Valuation Ratios
The PE ratio is 31.37 and the forward PE ratio is 16.88. Thermo Fisher Scientific's PEG ratio is 4.64.
| PE Ratio | 31.37 |
| Forward PE | 16.88 |
| PS Ratio | 4.63 |
| Forward PS | 2.9 |
| PB Ratio | 4.01 |
| P/FCF Ratio | 27.35 |
| PEG Ratio | 4.64 |
Enterprise Valuation
Thermo Fisher Scientific has an Enterprise Value (EV) of 225.99B.
| EV / Sales | 5.27 |
| EV / EBITDA | 19.59 |
| EV / EBIT | 26.08 |
| EV / FCF | 31.1 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.63.
| Current Ratio | 1.66 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 2.71 |
| Debt / FCF | 4.3 |
| Interest Coverage | 5.28 |
Financial Efficiency
Return on Equity is 12.78% and Return on Invested Capital is 7.72%.
| Return on Equity | 12.78% |
| Return on Assets | 6.51% |
| Return on Invested Capital | 7.72% |
| Revenue Per Employee | $343.03K |
| Profits Per Employee | $50.68K |
| Employee Count | 125,000 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 4.98 |
Taxes
| Income Tax | 657M |
| Effective Tax Rate | 9.34% |
Stock Price Statistics
The stock price has increased by -25.18% in the last 52 weeks. The beta is 0.87, so Thermo Fisher Scientific's price volatility has been higher than the market average.
| Beta | 0.87 |
| 52-Week Price Change | -25.18% |
| 50-Day Moving Average | 497.87 |
| 200-Day Moving Average | 552.58 |
| Relative Strength Index (RSI) | 37.25 |
| Average Volume (20 Days) | 2.18M |
Income Statement
In the last 12 months, Thermo Fisher Scientific had revenue of 42.88B and earned 6.33B in profits. Earnings per share was 16.58.
| Revenue | 42.88B |
| Gross Profit | 18.11B |
| Operating Income | 7.34B |
| Net Income | 6.33B |
| EBITDA | 11.54B |
| EBIT | 8.43B |
| Earnings Per Share (EPS) | 16.58 |
Balance Sheet
The company has 4.01B in cash and 31.27B in debt, giving a net cash position of -27.27B.
| Cash & Cash Equivalents | 4.01B |
| Total Debt | 31.27B |
| Net Cash | -27.27B |
| Retained Earnings | 53.1B |
| Total Assets | 97.32B |
| Working Capital | 8.8B |
Cash Flow
In the last 12 months, operating cash flow was 8.67B and capital expenditures -1.4B, giving a free cash flow of 7.27B.
| Operating Cash Flow | 8.67B |
| Capital Expenditures | -1.4B |
| Free Cash Flow | 7.27B |
| FCF Per Share | 19.02 |
Margins
Gross margin is 42.23%, with operating and profit margins of 17.11% and 14.77%.
| Gross Margin | 42.23% |
| Operating Margin | 17.11% |
| Pretax Margin | 16.41% |
| Profit Margin | 14.77% |
| EBITDA Margin | 26.9% |
| EBIT Margin | 17.11% |
| FCF Margin | 16.95% |
Dividends & Yields
TMO pays an annual dividend of $1.99, which amounts to a dividend yield of 0.31%.
| Dividend Per Share | $1.99 |
| Dividend Yield | 0.31% |
| Dividend Growth (YoY) | 10.26% |
| Payout Ratio | 12.03% |
| Earnings Yield | 3.19% |
| FCF Yield | 3.66% |
Analyst Forecast
The average price target for TMO is $659, which is 52.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $659 |
| Price Target Difference | 52.5% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
Stock Splits
The last stock split was on Jun 6, 1996. It was a forward split with a ratio of 3:2.
| Last Split Date | Jun 6, 1996 |
| Split Type | forward |
| Split Ratio | 3:2 |
Scores
| Altman Z-Score | 2.9 |
| Piotroski F-Score | 7 |